Update on Breast Imaging and Multi-modality Biopsy: Enhancing Patient Care through Advanced Techniques

The field of breast imaging is rapidly evolving, with significant advancements in digital breast tomosynthesis, breast ultrasound, contrast-enhanced mammography, molecular breast imaging, and breast MRI. This comprehensive update covers the latest trends and future directions in breast imaging, as well as cutting-edge biopsy methods for each modality.

Target Audience

This activity is specifically designed for radiologists and healthcare professionals with an interest in breast imaging and breast biopsy. By attending this update, participants will gain valuable insights into the latest research and clinical applications in breast imaging.

Goals and Objectives

Upon completing this activity, learners will be able to:

• Identify current trends and future directions in breast imaging from both research and clinical perspectives.
• Describe the latest applications of breast imaging biopsy techniques and their impact on patient care.
• Identify practice and patient care improvement opportunities.
• Provide timely and new information on current and new applications of breast imaging to improve patient care and detect early breast cancer.

Faculty Disclosures

In accordance with accreditation requirements, we are pleased to provide the following disclosures for our esteemed faculty members:

Module 1

• Stamatia Destounis: Receives institutional research grants for research projects with iCAD and Hologic Inc.
• Sarah Friedewald: Receives consulting fees and has a research grant from Hologic, Inc. Dr. Friedewald also has a research grant as the principal investigator from Google.
• Liane Philpotts: Has nothing to disclose.
• Jessica Leung: Receives stock shares as a member of the Scientific Advisory Board for Subtle Medical. Dr. Leung also receives an honorarium as a panelist for GE Healthcare and an honorarium as a member of the Scientific Advisory Board for Seno. Additionally, Dr. Leung receives an honorarium as a member of the Contrast Advisory Board for Bracco Diagnostics.

Module 2

• Haydee Ojeda-Fournier: Receives consulting fees from ViewPoint Medical and stock options from Curemetrix.
• Linda Moy: Is a Principal investigator on a research grant for Siemens Healthcare and an advisor for Lunit Insight and iCAD. Dr. Moy also serves on the RSNA Editorial Board for Radiology.
• Laurie Margolies: Is on the medical advisory board for Screenpoint Medical.
• Janice Sung: Is the principal investigator of a research study from GE for a research grant.

By staying up-to-date with the latest advancements in breast imaging and biopsy techniques, healthcare professionals can provide better patient care and improve outcomes for individuals with breast cancer.